Bibliography
- KRISHNASWAMY G, KELLEY J, JOHNSON D et al: The human mast cell: functions in physiology and disease. Front. Biosci. (2001) 6:D1109–1127.
- COCKS TM, MOFFATT JD: Protease-activated receptor-2 (PAR2) in the airways. Puha Pharmacy] Ther. (2001) 14(3):183–191.
- RICE KD, SPRENGLER PA: Therapeutic applications and design of mast cell tryptase inhibitors. CWT. Opin Drug Discov. Dev. (1999) 2(5):463–474.
- ••Excellent review from the group with anextensive knowledge of tryptase inhibition.
- GANGLOFF AR: Tryptase inhibitors in the treatment of pulmonary diseases. Curr. Opin. Investig. Drugs (2000) 1(1):79–85.
- KRISHNA MT, CHAUHAN A, LITTLE L et al.: Inhibition of mast cell tryptase by inhaled APC 366 attenuates allergen-induced late-phase airway obstruction in asthma. I Allergy Clin. Immunol. (2001) 107(6):1039–1045.
- KATZ BA, CLARK JM, FINER-MOORE JS et al.: Design of potent selective zinc-mediated serine protease inhibitors. Nature (1998) 391:608–612.
- ONO S, KUWAHARA S, TAKEUCHI M et al: Syntheses and evaluation of amidinobenzofuran derivatives as tryptase inhibitors. Bioorg. Med. Chem. Lett. (1999) 9(23):3285–3290.
- WRIGHT CE, HAVILL AM, MIDDLETON SC et al: Inhibition of allergen-induced pulmonary responses by the selective tryptase inhibitor 1, 5-bis-{4-R3-carbamimidoyl-benzenesulfonyl-amino)methyll-phenoxylpentane (AMG-126737). Biochem. Pharmacol. (1999) 58(12):1989–1996.
- Anti-inflammatory aryl pare- aminomethylbenzoate derivatives. Expert Opin. Ther. Patents (2000) 10(4):501–505.
- OH SW, PAE CI, LEE DK et al: Tryptaseinhibition blocks airway inflammation in a mouse asthma model. ..J. Immunol (2002) 168(4):1992–2000.